Predictive single nucleotide polymorphism markers for acute oral mucositis in patients with nasopharyngeal carcinoma treated with radiotherapy

被引:17
|
作者
Le, Ziyu [1 ,3 ]
Niu, Xiaoshuang [1 ,3 ]
Chen, Ying
Ou, Xiaomin [1 ,3 ]
Zhao, Guoqi [4 ]
Liu, Qi [4 ]
Tu, Wenzhi [4 ]
Hu, Chaosu [1 ,3 ]
Kong, Lin [1 ,3 ]
Liu, Yong [2 ,3 ]
机构
[1] Fudan Univ, Shanghai Canc Ctr, Dept Radiat Oncol, Shanghai 200032, Peoples R China
[2] Fudan Univ, Shanghai Canc Ctr, Canc Res Inst, Shanghai 200032, Peoples R China
[3] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China
[4] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Radiat Oncol, Shanghai 201620, Peoples R China
基金
中国国家自然科学基金;
关键词
genetic polymorphism; nasopharyngeal carcinoma; radiotherapy; oral mucositis; ZNF24; PROGRESSION-FREE SURVIVAL; NORMAL TISSUE-REACTIONS; DSB REPAIR GENES; NF-KAPPA-B; NECK-CANCER; PHASE-III; CONCURRENT CHEMORADIOTHERAPY; HEPATOCELLULAR-CARCINOMA; CELL-PROLIFERATION; RADIATION-THERAPY;
D O I
10.18632/oncotarget.18450
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to investigate the association between the susceptibility of severe oral mucositis (OM) in Chinese nasopharyngeal carcinoma (NPC) patients treated with radiotherapy and single nucleotide polymorphisms (SNPs) across the whole genome. SNPs were screened in a total of 24 patients with NPC and an additional 6 were subjected to mRNA expression analysis. Patients were subdivided into CTC 0-2 (CTC toxicity grade 0, 1, and 2) and CTC 3+ (CTC toxicity grade 3 and above) groups according to their CTC (common toxicity criteria) scores. The GTEx dataset was used to performed eQTL analyses and in-vitro functional assays were performed for eQTL-associated genes. Our data identified 7 functional SNPs associated with the development of OM. We observed that rs11081899-A, located in the 5'-UTR of the ZNF24 gene, was significantly correlated with a higher risk of severe mucositis (OR = 14.631, 95% CI = 2.61-105.46, p = 1.2 x 10(-4)), and positively associated with ZNF24 mRNA expression (p = 4.1 x 10(-6)) from GTEx dataset. In addition, high ZNF24 mRNA expression was associated with severe OM in patients with NPC (p = 0.02). Further functional assays revealed that ZNF24 knockdown reduced p65 expression and suppressed TNF-alpha-induced NF-kappa B activation and pro-inflammatory cytokines release. These findings suggested that rs11081899-A may be a genetic susceptibility factor for radiation-induced OM in patients with NPC, although its value in clinical application needs to be further verified in a large cohort. Also, we suggested that downregulation of ZNF24 may attenuate the development of mucositis by suppressing NF-kappa B activation.
引用
收藏
页码:63026 / 63037
页数:12
相关论文
共 50 条
  • [41] Dose escalation for patients with locally advanced nasopharyngeal carcinoma treated with radiotherapy alone
    Yeh, Shyh-An
    Huang, Yu-Jie
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (04): : 401 - 405
  • [42] Clinical outcomes of patients with nasopharyngeal carcinoma treated with antibiotics for radiation-induced mucositis: a retrospective study
    Weng, JingJin
    Wei, Jiazhang
    Li, Min
    Lu, Jinlong
    Qin, Yangda
    Liu, Fei
    Xiong, Weiming
    Qu, Shenhong
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (03)
  • [43] The effects of recombinant human granulocyte colony-stimulating factor mouthwash on radiotherapy-induced oral mucositis in locally advanced nasopharyngeal carcinoma patients
    Liang, Gai
    Du, Wei
    Ke, Qinghua
    Huang, Bing
    Yang, Jiyuan
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 26 (03): : 409 - 413
  • [44] Assessment and prevalence of concomitant chemo-radiotherapy-induced oral mucositis in patients with oral squamous cell carcinoma
    Minhas, Sadia
    Sajjad, Aneequa
    Chaudhry, Rabia Mushtaq
    Zahid, Hamza
    Shahid, Azfar
    Kashif, Muhammad
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2021, 51 (02) : 675 - 684
  • [45] A functional single nucleotide polymorphism site detected in nasopharyngeal carcinoma-associated transforming gene Tx
    Ren, W
    Zheng, H
    Li, M
    Deng, L
    Li, XL
    Pan, KF
    Lu, YY
    Cao, Y
    CANCER GENETICS AND CYTOGENETICS, 2005, 157 (01) : 49 - 52
  • [46] Evaluation of quality of life of nasopharyngeal carcinoma patients treated in a single institution
    Gokce, Tumay
    Karadogan, Ilker
    Capanoglu, Doga
    Ozkutuk, Nilay
    HEALTHMED, 2012, 6 (04): : 1216 - 1222
  • [47] Apoptotic and inflammation markers in oral mucositis in head and neck cancer patients receiving radiotherapy: preliminary report
    Arsinoi Xanthinaki
    Ourania Nicolatou-Galitis
    Pavlina Athanassiadou
    Maria Gonidi
    Vassilis Kouloulias
    Anastasia Sotiropoulou-Lontou
    George Pissakas
    Konstantinos Kyprianou
    John Kouvaris
    Efstratios Patsouris
    Supportive Care in Cancer, 2008, 16 : 1025 - 1033
  • [48] Apoptotic and inflammation markers in oral mucositis in head and neck cancer patients receiving radiotherapy: preliminary report
    Xanthinaki, Arsinoi
    Nicolatou-Galitis, Ourania
    Athanassiadou, Pavlina
    Gonidi, Maria
    Kouloulias, Vassilis
    Sotiropoulou-Lontou, Anastasia
    Pissakas, George
    Kyprianou, Konstantinos
    Kouvaris, John
    Patsouris, Efstratios
    SUPPORTIVE CARE IN CANCER, 2008, 16 (09) : 1025 - 1033
  • [49] Ulinastatin in the treatment of radiotherapy-induced oral mucositis in locoregionally advanced nasopharyngeal carcinoma: a phase 3 randomized clinical trial
    Wang, Xuguang
    Wu, Haijun
    Lei, Feng
    Liu, Zhigang
    Shen, Guanzhu
    Hu, Xuefeng
    Ye, Yijing
    Zhu, Manyi
    Huang, Huageng
    Chen, Boyu
    Huang, Runda
    Zhao, Chong
    Miao, Jingjing
    Wang, Lin
    NATURE COMMUNICATIONS, 2025, 16 (01)
  • [50] Impact of dose volume parameters and clinical factors on acute radiation oral mucositis for locally advanced nasopharyngeal carcinoma patients treated with concurrent intensity-modulated radiation therapy and chemoradiotherapy
    Li, Kaixin
    Yang, Ling
    Xin, Peiling
    Chen, Yuanyuan
    Hu, Qiang-ying
    Chen, Xiao-zhong
    Chen, Ming
    ORAL ONCOLOGY, 2017, 72 : 32 - 37